Injectable Drug Delivery Devices Market Information by By Devices (Conventional Injection Devices, Self-Injection Devices), By Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Cancer), By Usage Pattern (Curative pattern, Immunization), By Site of Delivery (Intramuscular, Subcutaneous, Intradermal), By Distribution Channel (Hospital & Retail Pharmacies, Online platforms), By Facility of Use (Hospitals and Clinics, Home Care Settings) and By Region – Global Forecasts till 2023
Advances in technology and innovation are permitting their use in progressively complex delivery systems. A range of gadgets fall under the section of injectable drug delivery devices including needle-free injectors, auto and pen injectors and conventional syringes. Interest for such gadgets has kept on expanding lately as they are being utilized to treatment of ailments that seeing a high rate of prevalence. Presentation of cutting edge gadgets with predominant functional abilities is positively affecting the global injectable drug delivery devices market. Other factor that can be connected with the market’s development incorporate expanding pervasiveness of interminable sicknesses, developing appropriation of self-injectable gadgets, and rising FDA endorsements. The market has recorded the growth rate of 11.5% during the forecast period (2018-2023).
Request For Free Sample- https://www.kennethresearch.com/sample-request-10077869
Based on its devices, the global injectable drug delivery devices market is divided into self-injection and conventional injection devices. On the basis of its therapeutic application, the market is sectioned as cancer, hormonal disorders and autoimmune diseases. By usage pattern, it is classified as immunization and curative pattern. Based on its site of delivery, the market is segmented as subcutaneous, intramuscular and intradermal. By facility of use, the market is divided as hospital and retail pharmacies and online platforms. Based on its facility of use, the market is categorized into home care settings and hospitals and clinics.
Geographically, the global injectable drug delivery devices market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
Becton, Dickinson and Company, Eli Lilly and Company, F.Hoffmann-La Roche AG, Eisai Co., Ltd., Antares Pharma, AstraZeneca, among others are the major players in the global injectable drug delivery devices market.
Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 List of Assumptions
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.2.1 Increasing prevalence of chronic diseases
4.2.2 Growing adoption of self-injectable devices
4.2.3 Rising FDA approvals
4.2.4 Drivers Impact Analysis
4.3.1 Risks of cross-contamination
4.3.2 Increasing cost of high-end products
4.3.3 Restraints Impact Analysis
4.4.1 Increasing campaigns of vaccination in developing economies of the Asia-Pacific region
4.5 Macroeconomic Indicators
4.6 Market Trend
4.6.1 Increasing use of auto-injectors against allergies
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation
21st Floor Suite MA111,
New York, NY 10018
Phone: +1 313 462 0609